Symbol Name ID |
Fto
FTO alpha-ketoglutarate dependent dioxygenase MGI:1347093 |
* | Aspects of the system are reported to show a normal phenotype. |
Darker colors indicate more annotations |
Human Phenotypes | Increased LDL cholesterol concentration |
Hypercholesterolemia |
Hypertriglyceridemia |
Decreased resting energy expenditure |
Glucose intolerance |
Diabetes mellitus |
Type II diabetes mellitus |
Impaired glucose tolerance |
Insulin resistance |
Calcification of the aorta |
Disease(s) Associated with FTO | ||||||||||
aortic valve disease 2 | ||||||||||
coronary artery disease | ||||||||||
obesity | ||||||||||
type 2 diabetes mellitus |
Mouse Phenotypes | homeostasis/metabolism phenotype |
decreased susceptibility to diet-induced obesity |
increased susceptibility to diet-induced obesity |
increased circulating glucose level |
abnormal circulating hormone level |
increased circulating adrenaline level |
increased circulating glucagon level |
decreased circulating insulin level |
decreased circulating insulin-like growth factor I level |
decreased circulating leptin level |
increased circulating leptin level |
increased circulating HDL cholesterol level |
decreased circulating LDL cholesterol level |
increased circulating cholesterol level |
increased circulating triglyceride level |
decreased circulating iron level |
decreased circulating alanine transaminase level |
decreased circulating aspartate transaminase level |
abnormal urine catecholamine level |
increased energy expenditure |
decreased lactate dehydrogenase level |
abnormal carbon dioxide production |
decreased carbon dioxide production |
increased carbon dioxide production |
abnormal oxygen consumption |
increased oxygen consumption |
decreased respiratory quotient |
increased respiratory quotient |
improved glucose tolerance |
abnormal metabolism |
increased basal metabolism |
|
Availability | Mouse Genotype | |||||||||||||||||||||||||||||||
FtoI367F/FtoI367F | ||||||||||||||||||||||||||||||||
Ftotm1.2Pzg/Ftotm1.2Pzg | ||||||||||||||||||||||||||||||||
Ftotm1.2Rdc/Ftotm1.2Rdc | * | |||||||||||||||||||||||||||||||
Ftotm1.3Pzg/Ftotm1.3Pzg | ||||||||||||||||||||||||||||||||
Ftotm1a(EUCOMM)Wtsi/Ftotm1a(EUCOMM)Wtsi | ||||||||||||||||||||||||||||||||
Ftotm1Urt/Ftotm1Urt | ||||||||||||||||||||||||||||||||
FtoI367F/Fto+ | ||||||||||||||||||||||||||||||||
Ftotm1Urt/Fto+ | ||||||||||||||||||||||||||||||||
Ftotm1.1Pzg/Ftotm1.1Pzg Tg(Nes-cre)1Kln/0 (conditional) |
||||||||||||||||||||||||||||||||
Ftotm1.1Rdc/Ftotm1.1Rdc (conditional) | * | |||||||||||||||||||||||||||||||
Ftotm1.1Rdc/Ftotm1.1Rdc Ndor1Tg(UBC-cre/ERT2)1Ejb/0 (conditional) |
* |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/09/2024 MGI 6.23 |
|
|